PriceTracker GLP-1

Status

ItemStatusSinceSource
Covered drugsFoundayo (tablet), Wegovy (injection or tablet), Zepbound (KwikPen only)Jul 1, 2026Medicare.gov
Who can use itCertain people with Medicare drug coverage (Part D)Jul 1, 2026Medicare.gov
Copayment$50 for a one-month supplyJul 1, 2026Medicare.gov
Prior authorizationValid through Dec 31, 2027, unless you change GLP-1sJul 1, 2026Medicare.gov
Type 2 diabetes, sleep apnea, fatty liverNot in the Bridge; your Part D plan might cover the drugJul 1, 2026Medicare.gov

In the regulator’s own words

"Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) · Wegovy® (injection or tablet) · Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens)."
Medicare.gov, Weight loss drugs, read Oct 3, 2026
"You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)."
Medicare.gov, Weight loss drugs, read Oct 3, 2026
"Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s."
Medicare.gov, Weight loss drugs, read Oct 3, 2026

This page reports what the regulator has published, in its words. It is not legal or medical advice.

Statuses change. Prices change more.

One email a week: the cheapest GLP-1 program and any real price moves.

Compare every GLP-1